Patent №
US 6,589,935
Granted
2003-07-08
Filed 1998
Owner
INCYTE PHARMACEUTICALS, INC.
Lab
—
AI components
1
planning
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
09046572
The invention provides a human insulin receptor tyrosine kinase substrate (IRS-p53h) and polynucleotides which identify and encode IRS-p53h. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of IRS-p53h.
AI classification
Ownership
INCYTE PHARMACEUTICALS, INC.
assignment · 93220780
Assignors
HILLMAN, JENNIFER L., CORLEY, NEIL C., GUEGLER, KARL J., BAUGHN, MARIAH
On an employer assignment, the assignors are typically the inventors.